199 related articles for article (PubMed ID: 25082305)
1. Transfemoral aortic valve implantation of Edwards SAPIEN XT without predilatation is feasible.
Möllmann H; Kim WK; Kempfert J; Blumenstein J; Liebetrau C; Nef H; Van Linden A; Walther T; Hamm C
Clin Cardiol; 2014 Nov; 37(11):667-71. PubMed ID: 25082305
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
[TBL] [Abstract][Full Text] [Related]
3. Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe.
Conradi L; Seiffert M; Schirmer J; Koschyk D; Blankenberg S; Reichenspurner H; Diemert P; Treede H
Eur J Cardiothorac Surg; 2014 Jul; 46(1):61-6. PubMed ID: 24335266
[TBL] [Abstract][Full Text] [Related]
4. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
5. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
6. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
8. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.
Greif M; Lange P; Mair H; Becker C; Schmitz C; Steinbeck G; Kupatt C
Clin Res Cardiol; 2012 Dec; 101(12):993-1001. PubMed ID: 22729757
[TBL] [Abstract][Full Text] [Related]
10. Prior balloon valvuloplasty versus DIRECT transcatheter Aortic Valve Implantation (DIRECTAVI): study protocol for a randomized controlled trial.
Leclercq F; Robert P; Labour J; Lattuca B; Akodad M; Macia JC; Gervasoni R; Roubille F; Gandet T; Schmutz L; Nogue E; Nagot N; Albat B; Cayla G
Trials; 2017 Jul; 18(1):303. PubMed ID: 28676065
[TBL] [Abstract][Full Text] [Related]
11. Aortic Valve Predilatation with a Small Balloon, without Rapid Pacing, prior to Transfemoral Transcatheter Aortic Valve Replacement.
Shivaraju A; Thilo C; Sawlani N; Ott I; Schunkert H; von Scheidt W; Kastrati A; Kasel AM
Biomed Res Int; 2018; 2018():1080597. PubMed ID: 29854723
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve implantation without prior balloon valvuloplasty is associated with less pronounced markers of myocardial injury.
Mirna M; Wernly B; Eder S; Lichtenauer M; Prinz E; Wintersteller W; Jung C; Hoppe U; Hammerer M
J Cardiovasc Surg (Torino); 2020 Apr; 61(2):243-249. PubMed ID: 30303343
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
15. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.
Conradi L; Schaefer A; Seiffert M; Schirmer J; Schaefer U; Schön G; Blankenberg S; Reichenspurner H; Treede H; Diemert P
Clin Res Cardiol; 2015 Sep; 104(9):735-42. PubMed ID: 25725778
[TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
17. Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry).
Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Schofer J; Hildick-Smith D; Pilgrim T; Abizaid A; Zweiker D; Testa L; Taramasso M; Wolf A; Webb JG; Sedaghat A; Van der Heyden JAS; Ziviello F; MacCarthy P; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Eitan A; Alsanjari O; Asami M; Windecker S; Siqueira D; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Jensen CJ; Naber CK; Alenezi A; Wood DA; Sinning JM; Brouwer J; Tzalamouras V; Van Mieghem NM; Colombo A; Latib A
Am J Cardiol; 2020 May; 125(9):1369-1377. PubMed ID: 32098656
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
19. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
20. Radiation Exposure and Contrast Volume Differ between Transapical and Transfemoral Aortic Valve Implantation with the Edwards SAPIEN Aortic Valve.
Hartrumpf M; Erb M; Zytowski M; Kuehnel RU; Aigner S; Butter C; Albes J
Thorac Cardiovasc Surg; 2015 Sep; 63(6):479-86. PubMed ID: 25703634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
